Huadong Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	4,375	5,276	4,663	3,996	4,032	3,198
Cash & Short-Term Investments	4,375	5,276	4,663	3,996	4,032	3,198
Cash Growth	-7.68%	13.15%	16.69%	-0.90%	26.09%	33.10%
Accounts Receivable	11,779	10,114	8,896	8,210	6,940	6,966
Other Receivables	782.16	402.87	291.14	284.18	223.92	87.63
Receivables	12,561	10,517	9,188	8,494	7,164	7,054
Inventory	5,200	4,776	4,290	4,495	3,975	4,068
Prepaid Expenses	-	0.09	15.07	-	-	-
Other Current Assets	583.79	482.3	340.46	582.21	316.04	336.21
Total Current Assets	22,721	21,052	18,497	17,568	15,487	14,656
Property, Plant & Equipment	5,480	5,409	5,204	5,021	4,813	4,661
Long-Term Investments	2,128	2,147	2,101	2,020	1,243	1,076
Goodwill	2,935	2,913	2,599	2,441	2,139	1,470
Other Intangible Assets	3,735	3,645	2,334	2,280	2,233	1,463
Long-Term Deferred Tax Assets	256.99	221.85	187.81	152.84	143.65	137.83
Long-Term Deferred Charges	1,344	1,056	1,013	657.81	12.43	8.81
Other Long-Term Assets	1,330	1,436	1,574	1,051	925.63	729.86
Total Assets	39,929	37,879	33,509	31,192	26,996	24,201
Accounts Payable	8,770	7,044	6,102	5,902	4,520	4,501
Accrued Expenses	238.4	650.63	554.92	518.92	920.63	528.8
Short-Term Debt	1,771	2,665	1,197	1,337	1,627	1,808
Current Portion of Long-Term Debt	107.51	212.41	80.92	36.9	174.18	40.05
Current Portion of Leases	-	67.3	81.98	75.29	66.86	-
Current Income Taxes Payable	400.75	370.26	259.27	154.95	261.24	166.43
Current Unearned Revenue	117.2	174.72	136.85	147.64	119.49	95.34
Other Current Liabilities	3,171	2,610	2,389	1,979	1,576	1,494
Total Current Liabilities	14,576	13,794	10,803	10,153	9,266	8,634
Long-Term Debt	298.87	14.26	520.76	1,051	139.18	151.61
Long-Term Leases	100.89	71.86	56.7	84.61	80.89	-
Long-Term Unearned Revenue	200.61	183.86	171.06	126.12	83.52	81.63
Long-Term Deferred Tax Liabilities	196.7	197.38	184.37	202.08	184.91	88.74
Other Long-Term Liabilities	58.98	53.7	191.61	398.67	300.99	66.28
Total Liabilities	15,432	14,315	11,927	12,016	10,055	9,022
Common Stock	1,754	1,754	1,754	1,754	1,750	1,750
Additional Paid-In Capital	2,418	2,551	2,446	2,378	2,230	2,158
Retained Earnings	19,969	18,852	16,972	14,639	12,647	10,714
Treasury Stock	-40.77	-46.8	-84.52	-104.65	-	-
Comprehensive Income & Other	32.76	-50.6	-40.34	-88.55	-47.77	-2.19
Total Common Equity	24,133	23,060	21,048	18,578	16,579	14,620
Minority Interest	363.45	503.7	534.65	598.52	361.94	559.59
Shareholders' Equity	24,496	23,564	21,582	19,176	16,941	15,179
Total Liabilities & Equity	39,929	37,879	33,509	31,192	26,996	24,201
Total Debt	2,279	3,031	1,938	2,586	2,089	1,999
Net Cash (Debt)	2,097	2,246	2,726	1,411	1,944	1,199
Net Cash Growth	-11.56%	-17.61%	93.21%	-27.43%	62.16%	267.04%
Net Cash Per Share	1.19	1.28	1.56	0.81	1.11	0.69
Filing Date Shares Outstanding	1,730	1,759	1,752	1,750	1,750	1,750
Total Common Shares Outstanding	1,730	1,759	1,752	1,750	1,750	1,750
Working Capital	8,144	7,258	7,694	7,415	6,221	6,022
Book Value Per Share	13.95	13.11	12.01	10.62	9.47	8.36
Tangible Book Value	17,463	16,502	16,115	13,856	12,207	11,687
Tangible Book Value Per Share	10.09	9.38	9.20	7.92	6.98	6.68
Buildings	-	2,483	2,299	1,865	1,503	1,228
Machinery	-	5,010	4,438	4,282	3,385	2,817
Construction In Progress	-	836.74	913.15	873.16	1,582	2,240

Source: S&P Global Market Intelligence. Standard template. Financial Sources.